GlassScriptPhysician profile
Warren Huber
NPI 1073876553
$50,184.76
in general payments reported to CMS, 2019-2025
11 companies · $9,904 in 2025
The $9,904 reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,727 · 2020: $419 · 2021: $698 · 2022: $18K · 2023: $14K · 2024: $803 · 2025: $9,904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $6,240 · Food and Beverage: $1,592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,400.00 |
| Travel and Lodging | $6,239.77 |
| Food and Beverage | $1,592.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $32,792.27 | 2022-2025 | Myosure Tissue Removal Device, None, Fluent Fluid Management System |
| Ferring Pharmaceuticals INC. | $14,074.50 | 2019-2025 | Menopur |
| Cytyc Surgical Products, LLC | $1,254.01 | 2023-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Organon LLC | $703.94 | 2021-2025 | Ganirelix Acetate, Pregnyl, Follistim Aq |
| Emd Serono, INC. | $411.80 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $399.74 | 2019-2021 | |
| Galen US INC | $203.80 | 2020-2022 | |
| Aspira Women'S Health INC | $161.77 | 2022 | |
| Virtus Pharmaceuticals LLC | $80.05 | 2021-2022 | |
| Abbvie INC. | $62.71 | 2021-2022 | |
| Ferring Arzneimittel Gmbh | $40.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Huber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.